Search Results 21-30 of 986 for ✔핸드폰소액결제사이트 (010-9489-1116) 휴대폰정보이용료현금화✔
The purpose of this study is to test the hypertension (HTN) app-based intervention to see if it is more effective in improving uncontrolled HTN and HTN self- ...
This will help determine the safety and feasibility of using cell-based regenerative therapy as an additional treatment for the management of HLHS.
Success of cancer immunotherapy is limited by the ability of solid tumors to evade local and systemic antitumoral immune responses. Several mechanisms of tumor ...
Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date information regarding possible ...
Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...
About this study. The purpose of this research is to study immune cells called T cells and monocytes (types of blood cells that fight infection and can also ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Overview · Participation eligibility · Participating Mayo Clinic locations · More information ...
The primary outcome of this study is to determine whether or not the B cell targeting with Rituximab is more effective than Cyclosporine in inducing long term ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.